Chitosan microparticles intended for anti-caries DNA vaccine mucosal delivery: Synthesis, characterization and transfection

Abstract

In order to enhance the mucosal immunity of anti-caries DNA vaccine, chitosan-DNA microparticles for musocal vaccination were prepared by a coacervation method. The physicochemical structure of microparticles was investigated by a scanning electron microscope (SEM) and a cofocal laser scanning microscope (CLSM). For in-vitro studies, Hela cell was transfected by chitosan-DNA microparticles. The expression of proteins was measured by the immunohistochemical methods, and the cytotocity of chitosan in Hela cell line was determined by the MTT assay. The experimental results show that the microparticles are about 2–6 μm in size and spherical in shape. The encapsulation efficiency is 99%, and the DNA is almost captured in the micropraticles. Plasmid loaded into chitosan microparticles is distributed throughout these particles. The number of positive staining cells of chitosan-pGJA-P transfected cell is more than that of naked plasmid transfect cells, but less than that of Lipofect-DNA complex group. Chitosan was found to be less cytotoxic compared with lipofectin (p<0.01).

Keywords

chitosan microparticles / anti-caries / DNA vaccine / transfection

References

[1] Loesche W J. Role ofStreptococcus Mutans in Human Dental Decay. Microbiol. Rev., 1986, 50(4): 353-380.

[2] Fan M W, Bian Z, Guo J H, Jia R, Chen Z. DNA Vaccine EncodingStreptoccus Mutans Surface Protein Protected Gnotobiotic Rats from Caries. Chin. J. Stomatol, 2002, 37(1): 4-7. (in Chinese)

[3] Fan M W, Bian Z, Peng Z X, . A DNA Vaccine Encoding a Cellsurface Protein Antigen ofStreptococcus Mutans Protects Gnotobiotic Rats from Caries. J. Dent. Res., 2002, 81(7): 784-787.

[4] Guo J H, Fan M W, Bian Z, Jia R, Chen Z, Peng B. Construction and Expressionin vitro of a Targeted Fusion Anticaries DNA Vaccine. Chin. J. Stomatol, 2003, 38(3): 282-284. (in Chinese)

[5] Guo J H, Jia R, Fan M W, . Construction and Immunogenic Characterization of a Fusion Anti-caries DNA Vaccine against Pac and Glucosyltransferase I ofStreptoccus Mutans. J. Dent. Res., 2004, 83(3): 266-270.

[6] Luessen H L, De Leeuw B J, Langemeyer M, De Boer A G, Verhoef J C, Junginger H E. Mucoadhesive Polymers in Peroral Peptide Drug Delivery, IV, Carbomer and Chitosan Improve the Intestinal Absorption of the Peptide Drug Buserelinin vivo. Pharm. Res., 1996, 13(8): 1668-1672.

[7] Roy K, Mao H-Q, Huang S-K, Leong K W. Oral Gene Delivery with Chitosan DNA Nanoparticles Generates Immunologic Protection in a Murine Model of Peanut Allergy. Nature Med., 1999, 5(4): 387-391.

[8] Corsia Karin, Chellata Fatiha, Yahia L Hocine, Julio C. Fernandes Mesenchymal Stem Cells MG63 and HEK293 Transfection Using Chitosan-DNA Nanoparticles. Biomaterials, 2003, 24: 1255-1264.

[9] Sannan T, Kurita K, Iwakura Y. Studies on Chitin, II, Effect of Deacetylation on Solubility, Macromol. Chem., 1976, 177(12): 3589-3600.

[10] Yongmei Xu, Du Yumin. Effect of Molecular Structure of Chitosan on Protein Delivery Properties of Chitosan Nanoparticles. Int. J. Pharmac, 2003, 250(2): 215-226.

[11] S Hirano, H Seino, Y Akiyama, I Nonaka. Biocompatibility of Chitosan by Oral and Intravenous Administration.Polym. Eng. Sci., 1988, 897–901

[12] Lydyard P, Grossi C. The Lymphoid System.In: Immunology, 1998, 5:31–42

[13] van der Lubben I M, Konings F A J, Borchard G, J. C.. In Vivo Uptake of Chitosan Miassociated Croparticles by Murine Peyer’s Patches: Visualization Studies Using Confocal Laser Scanning Microscopy and Immunohistochemistry. J. Drug Target, 2001, 9(1): 39-47.

[14] Zhou S B, Deng X M, Li X H. Investigation on a Novel Corecoated Microspheres Protein Delivery System. J. Controlled Release, 2001, 75(1): 27-36.